NALOXONE AGUETTANT 0.4 mg/ml, solution for injection 10 ampoules of 1 ml
Active ingredients: Naloxone hydrochloride, Naloxone hydrochloride dihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 1 mlintramusculaire;intraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NALOXONE AGUETTANT 0,4 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse;sous-cutanée
- Presentation description
- 10 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- AGUETTANT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Jan 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66883896CIP73686386CIP133400936863866Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE NALOXONE ANHYDREsolution | 0,4 mg · 1 ml de solution injectable | FT |
| CHLORHYDRATE DE NALOXONE DIHYDRATÉsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.